These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22607196)

  • 1. Oroxylin A improves the sensitivity of HT-29 human colon cancer cells to 5-FU through modulation of the COX-2 signaling pathway.
    Ha J; Zhao L; Zhao Q; Yao J; Zhu BB; Lu N; Ke X; Yang HY; Li Z; You QD; Guo QL
    Biochem Cell Biol; 2012 Aug; 90(4):521-31. PubMed ID: 22607196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29.
    Du B; Jiang L; Xia Q; Zhong L
    Chemotherapy; 2006; 52(1):23-8. PubMed ID: 16340194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase.
    Réti A; Pap E; Adleff V; Jeney A; Kralovánszky J; Budai B
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):219-27. PubMed ID: 19830428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of non-steroidal anti-inflammatory drugs to enhance 5-fluorouracil efficacy in experimental systems].
    Réti A
    Magy Onkol; 2010 Dec; 54(4):377-81. PubMed ID: 21163769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways.
    Hwang JT; Ha J; Park OJ
    Biochem Biophys Res Commun; 2005 Jul; 332(2):433-40. PubMed ID: 15896711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
    Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F
    Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment.
    Yang SY; Miah A; Sales KM; Fuller B; Seifalian AM; Winslet M
    Int J Oncol; 2011 Jun; 38(6):1695-702. PubMed ID: 21424124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells.
    Li J; Hou N; Faried A; Tsutsumi S; Takeuchi T; Kuwano H
    Ann Surg Oncol; 2009 Mar; 16(3):761-71. PubMed ID: 19116755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of cyclooxygenase-2 inhibition with celecoxib combined with 5-FU enhances tumor cell apoptosis and antitumor efficacy in a subcutaneous implantation tumor model of human colon cancer.
    Zhang DQ; Guo Q; Zhu JH; Chen WC
    World J Surg Oncol; 2013 Jan; 11():16. PubMed ID: 23347845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil.
    Calviello G; Di Nicuolo F; Serini S; Piccioni E; Boninsegna A; Maggiano N; Ranelletti FO; Palozza P
    Cancer Chemother Pharmacol; 2005 Jan; 55(1):12-20. PubMed ID: 15365767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of 5-fluorouracil and the flavanoid oroxylin A on HepG2 human hepatocellular carcinoma and on H22 transplanted mice.
    Zhao L; Chen Z; Wang J; Yang L; Zhao Q; Wang J; Qi Q; Mu R; You QD; Guo QL
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):481-9. PubMed ID: 19585117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells.
    Hwang JT; Kim YM; Surh YJ; Baik HW; Lee SK; Ha J; Park OJ
    Cancer Res; 2006 Oct; 66(20):10057-63. PubMed ID: 17047069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo.
    Li HN; Nie FF; Liu W; Dai QS; Lu N; Qi Q; Li ZY; You QD; Guo QL
    Toxicology; 2009 Mar; 257(1-2):80-5. PubMed ID: 19135124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma.
    Tang XY; Zhu YQ; Tao WH; Wei B; Lin XL
    Postgrad Med J; 2007 May; 83(979):338-43. PubMed ID: 17488865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
    Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
    Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The β6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer.
    Liu S; Wang J; Niu W; Liu E; Wang J; Peng C; Lin P; Wang B; Khan AQ; Gao H; Liang B; Shahbaz M; Niu J
    Cancer Lett; 2013 Jan; 328(2):325-34. PubMed ID: 23073477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.